Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/TGTX
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

TG Therapeutics Inc (TGTX) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

TG Therapeutics (TGTX) trades at $56.19, down 2.16% on the day, with a bullish technical signal driven by moving averages. The company reported strong revenue growth, with 2025 revenue at $616.29M and net income of $447.18M, though it missed Q2 2026 EPS estimates. Recent news highlights BRIUMVI's market share gains and buyout speculation, while a legal investigation adds caution.
Outlook remains positive with analyst consensus targeting $80.50, but risks include earnings misses, competitive pressures, and legal scrutiny. The stock offers upside potential if BRIUMVI growth continues, yet investors should monitor execution and regulatory developments closely.
Read full analysis

Key Stats

  • Market Cap
    $8.60B
  • Volume
    1,605,185
  • Sector
    Health
  • 52W High
    $59.06
  • 52W Low
    $26.94
  • Typical Hold Time
    15 Days
  • Enterprise Value
    $8.80B
  • Div Yield
    -
  • Trading Activity
    -
$56.68
52W Low: $26.94
12 Mar 2026
52W High: $59.06
09 Jul 2026

Track TG Therapeutics Inc (TGTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TG Therapeutics Inc has traded between a low of $26.94 and a high of $59.06, highlighting its annual price range. Buy and sell TG Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Most Recent News

Content is generated by Aura AI

Patients switching from obesity injections to Novo's Wegovy pill lost additional weight after 3 months.

Novo Nordisk's analysis of real-world data shows that patients who switched from obesity injections like Wegovy or Lilly's Zepbound to Novo's new Wegovy pill continued to lose weight, shedding about 4% of their body weight on average after three mont...

Market News
4 hours ago
CNBC
Bullish
news icon
Patients switching from obesity injections to Novo's Wegovy pill lost additional weight after 3 months.

AbbVie’s ABBV-295 shows promising weight loss and flexible dosing in Phase 1 obesity trial

AbbVie announced positive Phase 1 results for ABBV-295, a long-acting amylin analog for obesity treatment, showing meaningful weight loss of up to 9.8% over 12-13 weeks with weekly, biweekly, and monthly dosing options. The drug demonstrated a half-l...

Company Fundamentals
4 hours ago
PRNewsWire
Bullish
news icon
AbbVie’s ABBV-295 shows promising weight loss and flexible dosing in Phase 1 obesity trial

GameStop insiders buy $57M in shares after strong Q2, sparking stock rally and analyst buy rating.

GameStop's CEO Ryan Cohen and other insiders bought a total of $57 million in shares in September, reversing previous selling trends. This insider buying followed a strong Q2 earnings report that showed record operating income and boosted collectible...

Market News
4 hours ago
Finbold
Bullish
news icon
GameStop insiders buy $57M in shares after strong Q2, sparking stock rally and analyst buy rating.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $8.60B
  • Volume
    1,605,185
  • Sector
    Health
  • 52W High
    $59.06
  • 52W Low
    $26.94
  • Typical Hold Time
    15 Days
  • Enterprise Value
    $8.80B
  • Div Yield
    -
  • Trading Activity
    -
$56.68
52W Low: $26.94
12 Mar 2026
52W High: $59.06
09 Jul 2026

Track TG Therapeutics Inc (TGTX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, TG Therapeutics Inc has traded between a low of $26.94 and a high of $59.06, highlighting its annual price range. Buy and sell TG Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!